为了提高BIM技术使用率,依据计划行为理论,采用文献综述法对2016—2022年中国知网数据库和Web of Science数据库进行相关文献检索,整理出13个影响因素;通过DEMATEI-ISM法得到7个关键因素并构建因素间的结构层次图;基于决策者视角,指出BI...为了提高BIM技术使用率,依据计划行为理论,采用文献综述法对2016—2022年中国知网数据库和Web of Science数据库进行相关文献检索,整理出13个影响因素;通过DEMATEI-ISM法得到7个关键因素并构建因素间的结构层次图;基于决策者视角,指出BIM技术使用率关键影响因素分别是决策者对BIM技术使用率的行为态度、主观规范、知觉行为控制、系统的BIM教育及组织资源就绪程度、人员对BIM的认知和政府部门激励政策。展开更多
Atroposelective synthesis of N-N atropisomers is an emerging area but remains underexplored;in particular,the synthesis of N-N benzimidazole atropisomers is still unprecedented.Herein,the first enantioselective synthe...Atroposelective synthesis of N-N atropisomers is an emerging area but remains underexplored;in particular,the synthesis of N-N benzimidazole atropisomers is still unprecedented.Herein,the first enantioselective synthesis of N-N benzimidazole atropisomers via the palladium-catalyzed de novo construction of benzimidazole skeleton is presented.With readily available palladium catalyst and biphosphine ligand,a broad range of nonbiaryl benzimidazole and indole-benzimidazole atropisomers were conveniently ac-cessed in high yields and with excellent enantioselectivities.Significantly,these N-N benzimidazole atropisomers showed great anti-tumor activity and selectivity to breast cancer MCF-7 cells.The simple catalytic system,broad substrate scope,high enantioselectivi-ty,and good bioactivity make this approach highly attractive.展开更多
文摘为了提高BIM技术使用率,依据计划行为理论,采用文献综述法对2016—2022年中国知网数据库和Web of Science数据库进行相关文献检索,整理出13个影响因素;通过DEMATEI-ISM法得到7个关键因素并构建因素间的结构层次图;基于决策者视角,指出BIM技术使用率关键影响因素分别是决策者对BIM技术使用率的行为态度、主观规范、知觉行为控制、系统的BIM教育及组织资源就绪程度、人员对BIM的认知和政府部门激励政策。
基金supported by Taishan Scholar Youth Expert Program in Shandong Province (tsqn201909096)National Natural Science Foundation of China (22371152)+1 种基金Shandong Provincial Natural Science Foundation Project (ZR2023JQ006,ZR2022MB021)the startup fund from Qingdao University.
文摘Atroposelective synthesis of N-N atropisomers is an emerging area but remains underexplored;in particular,the synthesis of N-N benzimidazole atropisomers is still unprecedented.Herein,the first enantioselective synthesis of N-N benzimidazole atropisomers via the palladium-catalyzed de novo construction of benzimidazole skeleton is presented.With readily available palladium catalyst and biphosphine ligand,a broad range of nonbiaryl benzimidazole and indole-benzimidazole atropisomers were conveniently ac-cessed in high yields and with excellent enantioselectivities.Significantly,these N-N benzimidazole atropisomers showed great anti-tumor activity and selectivity to breast cancer MCF-7 cells.The simple catalytic system,broad substrate scope,high enantioselectivi-ty,and good bioactivity make this approach highly attractive.
